We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Introduction to Protein Structure and Function
-
1. Nature’s strategies in the regulation of enzyme activity by modifiers
- Prof. Antonio Baici
- Creation of Protein Variability by Manipulation of Genes
-
3. Perspectives on biological catalysis
- Prof. Stephen Benkovic
-
4. Fundamentals and principles for engineering proteolytic activity
- Prof. Charles Craik
- Metabolic Diseases Caused by Genetic Mutation
-
5. Modifications of pyruvate handling in health and disease
- Prof. Mary Sugden
-
6. Mitochondrial fatty acid oxidation deficiencies
- Prof. Niels Gregersen
-
7. Inborn errors of ketone body metabolism
- Prof. Toshiyuki Fukao
-
8. Cathepsin K in bone and joint diseases
- Prof. Dieter Bromme
-
9. Fabry disease: alfa-galactosidase A deficiency and enzyme replacement therapy
- Prof. David Warnock
-
10. Acid beta-glucosidase/glucocerebrosidase (GCase)
- Prof. Gregory Grabowski
-
11. GM2 gangliosidosis future treatments 1
- Prof. Brian Mark
-
12. GM2 gangliosidosis future treatments 2
- Prof. Brian Mark
-
13. The neuronal ceroid lipofuscinoses
- Prof. Sandra Hofmann
- Disorders of Blood Coagulation
-
14. Advances in fibrinolysis
- Dr. Paul Kim
-
16. Structure of thrombin, a Janus-headed proteinase
- Prof. Wolfram Bode
-
18. Fibrinogen and factor XIII
- Prof. John Weisel
-
19. Factor VIII and haemophilia A
- Dr. Geoffrey Kemball-Cook
-
20. Factor IX
- Prof. Bruce Furie
-
21. The biology and pathobiology of von Willebrand factor
- Prof. David Lillicrap
-
22. Thrombotic thrombocytopenic purpura
- Prof. J. Evan Sadler
-
23. Fibrinolysis
- Prof. Edward Tuddenham
- Other Molecular and Metabolic Disorders
-
24. Glucose-6-phosphate dehydrogenase deficiency
- Dr. Jane Leopold
-
25. Cytochrome b5 reductase deficiency and hereditary methemoglobinemia
- Dr. Scott Reading
-
26. Sickle cell disease
- Prof. Martin H. Steinberg
-
27. Pyruvate kinase deficiency
- Prof. Alberto Zanella
-
28. Heritable disorders of collagen
- Dr. Heather Yeowell
-
29. Duchenne muscular dystrophy
- Prof. Jeff Chamberlain
- Archived Lectures *These may not cover the latest advances in the field
-
30. Protein crystallography
- Prof. Michael James
-
31. Regulation of blood coagulation by the serpin, antithrombin
- Prof. Steve Olson
-
32. Rhodopsin and retinitis pigmentosa
- Dr. Shalesh Kaushal
-
33. The physiology and pathology of coagulation factor XI
- Dr. David Gailani
-
34. Cytochrome b5 reductase deficiency and hereditary methemoglobinemia
- Prof. Josef Prchal
-
35. Metachromatic leukodystrophy
- Prof. Volkmar Gieselmann
-
36. Serpins and serpinopathies
- Dr. James Whisstock
-
38. Pleiotropic and epistatic genes in sickle cell anaemia
- Prof. Ronald Nagel
-
39. Genetic disorders of carbonic anhydrases II and IV
- Prof. William Sly
-
40. GM2 gangliosidoses
- Prof. Don Mahuran
-
41. Kinetic analysis of protein activity
- Prof. Antonio Baici
Printable Handouts
Navigable Slide Index
- Introduction
- Fibrinogen important functions
- Basic scheme of fibrin polymerization
- The 3 pairs of polypeptide chains of fibrinogen
- TEM fibrinogen images
- Structure of fibrinogen
- Biosynthesis of fibrinogen
- Diagram of the complementary binding sites
- Physical model of the protofibril
- Structure of protofibrils
- Schematic model of complementary binding sites
- Activation of factor XIII
- Formation of iso-peptide bonds in fibrin
- Factor XIII stabilizes fibrin
- Diagram of fibrin polymerization
- Fibrin fibers structure in TEM
- Specimen preparation for TEM: negative contrast
- Twisting of protofibrils around each other
- SEM of fibrin fibers images
- Branch points of fibrin fibers
- SEM of fibrin clots images (1)
- The kinetics of polymerization
- Fibrin is a viscoelastic polymer
- The unique mechanical properties of fibrin
- Fibrin clot formation: turbidity curves
- Stiffness as another measure of polymerization
- Another way to determine stiffness
- Binding of other proteins to fibrin(ogen)
- Light microscope images of fibrin clots
- SEM of fibrin clots images (2)
- Plasminogen activation and fibrin lysis
- Fragments from plasmin digestion of fibrin
- Electron micrographs of fibrinolysis
- Products of fibrinolysis
- Fibrin-plasmin interactions leading to cleavage (1)
- Fibrin-plasmin interactions leading to cleavage (2)
- Fibrinogen is necessary for platelet aggregation
- TEM images of rotary shadowed alphaIIb-beta3
- TEM images of fibrinogen-integrin complexes
- Illustration of platelet aggregation
- Dysfibrinogenemias
- Fibrinogen variants
- Evolution of fibrinogen
- Summary
Topics Covered
- Fibrinogen and factor XIII
- Structure
- Biosynthesis
- Fibrin polymerization
- Crosslinking
- Clot mechanical properties
- Interactions with other proteins
- Fibrinolysis
- Platelet aggregation
- Dysfibrinogenemias and variants
- Evolution
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Weisel, J. (2007, October 1). Fibrinogen and factor XIII [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/IRLK6555.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. John Weisel has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.